Log In
BCIQ
Print this Print this
 

CNTX-2022

  Manage Alerts
Collapse Summary General Information
Company Centrexion Therapeutics Corp.
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat musculoskeletal and dermatological pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today